NCT02371759View on ClinicalTrials.gov

Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2

PHASE3CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Diabetes MellitusLocal Anesthesia
Interventions
DRUG

L+C maxillary anesthesia

Maxillary anesthesia obtained by 2% lidocaine + clonidine (15 mcg/ml)

DRUG

L+C mandibular anesthesia

Mandibular anesthesia obtained by 2% lidocaine + clonidine (15 mcg/ml)

DRUG

L+E maxillary anesthesia

Maxillary anesthesia obtained by 2% lidocaine + epinephrine (1:80 000)

DRUG

L+E mandibular anesthesia

Mandibular anesthesia obtained by 2% lidocaine + epinephrine (1:80 000)

Trial Locations (1)

11000

School of Dental Medicine, University of Belgrade, Belgrade

All Listed Sponsors
lead

University of Belgrade

OTHER

NCT02371759 - Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2 | Biotech Hunter | Biotech Hunter